Φορτώνει......
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Due to the advantages in efficacy and safety compared with traditional chemotherapy drugs, targeted therapeutic drugs have become mainstream cancer treatments. Since the first tyrosine kinase inhibitor imatinib was approved to enter the market by the US Food and Drug Administration (FDA) in 2001, an...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Signal Transduct Target Ther |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Nature Publishing Group UK
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8165101/ https://ncbi.nlm.nih.gov/pubmed/34054126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41392-021-00572-w |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|